2026-08-032 min
CJC-1295 Side Effects: Human Trial Findings and FDA Safety Concerns
An evidence-based review of reactions reported in human research and FDA concerns involving compounded CJC-1295.
Reviewed by Clinical Trial Review TeamFDA Status
Approval, compounding and regulatory status of GH-axis compounds.
Open
2026-07-292 min
Sermorelin FDA Approval History: Geref, Discontinuation and Compounded Products
A regulatory history of sermorelin, including former Geref products, discontinuation and the status of compounded preparations.
Reviewed by CJC Axis Editorial Team2026-07-132 min
Sermorelin: Evidence Checklist and Evidence Boundaries
An evidence-led Sermorelin review focused on evidence checklist, human-study limits, regulatory context and claim verification.
Reviewed by Clinical Trial Review Team2026-07-132 min
Sermorelin: Research Gaps Map and Evidence Boundaries
An evidence-led Sermorelin review focused on research gaps map, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-132 min
Sermorelin: Glucose and Metabolic Context and Evidence Boundaries
An evidence-led Sermorelin review focused on glucose and metabolic context, human-study limits, regulatory context and claim verification.
Reviewed by Clinical Trial Review Team2026-07-132 min
Sermorelin: Healthy-Aging Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on healthy-aging claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-122 min
Sermorelin: Sleep Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on sleep claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-122 min
Sermorelin: Recovery and Injury Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on recovery and injury claims, human-study limits, regulatory context and claim verification.
Reviewed by CJC Axis Editorial Team2026-07-122 min
Sermorelin: Body Composition Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on body composition claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk